NICE process and methods
Appendix B: Criteria to appraise the validity of indicators
Appendix B: Criteria to appraise the validity of indicators
The indicator advisory committee advises on the progression of indicators in development using the following criteria to assess validity:
| Domain | Criteria |
|---|---|
|
Importance |
The indicator reflects a specific priority area identified by NHS England or Public Health England. The indicator relates to an area where there is known variation in practice. The indicator will lead to a meaningful improvement in outcomes. The indicator addresses under or over-treatment. |
|
Evidence base |
The indicator is derived from a high-quality evidence base. The indicator aligns with the evidence base. |
|
Specification |
The indicator has defined components necessary to construct the indicator, including numerator, denominator and exclusions. The indicator has a defined system or provider level at which the indicator is intended to be used. The indicator outlines an expected population size and if a minimum number of patients is required, related to its intended use. |
|
Feasibility |
The indicator is repeatable. The indicator is measuring what it is designed to measure. The indicator uses existing data fields or the burden of additional data collection is acceptable. |
|
Acceptability |
The indicator assesses performance that is attributable to or within the control of the audience. The results of the indicator can be used to improve practice. |
|
Risk |
The indicator has an acceptable risk of unintended consequences. |
Modified from MacLean et al (2018) Time Out — Charting a Path for Improving Performance Measurement N Engl J Med 2018 378:1757-1761